GEROSCIENCE

Clinical trials for GEROSCIENCE explained in plain language.

Never miss a new study

Get alerted when new GEROSCIENCE trials appear

Sign up with your email to follow new studies for GEROSCIENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a new pill slow down aging in women?

Disease control Recruiting now

This study is testing a dietary supplement called GLYLO to see if it can reduce harmful compounds in the body linked to aging and poor metabolic health. It will involve 30 overweight or obese postmenopausal women aged 45-65 who will take the supplement or a placebo for 6 months. …

Matched conditions: GEROSCIENCE

Phase: NA • Sponsor: Buck Institute for Research on Aging • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

GEROSCIENCE

Get alerted when new GEROSCIENCE trials appear

Can a new pill slow down aging in women?